Friday, 25 November 2016

Market Research on Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Hepatitis Viruses Diagnostic Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Viruses Diagnostic Tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.
Scope
- Extensive coverage of the Hepatitis Viruses Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hepatitis Viruses Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hepatitis Viruses Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Abbott Diagnostics Diagnostic Tests Access Bio, Inc. Alderon Biosciences, Inc. Alere Inc AutoGenomics Inc AXO Science SAS BCR Corp Beckman Coulter Inc Biokit, S.A. Biomagnetics Diagnostics Corporation Bio-Rad Laboratories Inc CeMines, Inc. Cepheid China Medical Technologies Inc Co-Diagnostics HBDC, Inc. Corgenix Medical Corp Da An Gene Co Ltd Diagnostics for the Real World (Europe) Ltd. DiaSorin S.p.A D-Kimia, LLC. Ecoli s.r.o. Enzo Biochem Inc Fast-track diagnostics S.a.r.l. Ferrer inCode SL French National Institute of Health and Medical Research genedrive plc Genera Biosystems Ltd GenMark Diagnostics Inc Goodgene Inc Hologic Inc Imperial College London MedMira Inc. Mindray Medical International Ltd MND Diagnostic LTD Molbio Diagnostics Pvt. Ltd. NanoDiagX OPKO Health Inc Orangelife Pathogenica Inc ProteinLogic Ltd Qiagen NV Quotient Limited Resultados y Calidad del Sistema Sanitario Publico de Andalucia Roche Diagnostics International Ltd Sansure Biotech Inc Siemens Healthcare GmbH Stanford University Syamala Srinivasa Life Sciences Pvt. Ltd The University of British Columbia University Medical Center Hamburg-Eppendorf University of Texas Medical Branch at Galveston University of Warwick Ustar Biotechnologies (Hangzhou) Ltd. Xiamen Zeesan Biotech Co.,Ltd
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home